RAFARM
"The annual investment
on research
amount to
7% of turnover."
RAFARM has proven constant growth and high penetration in all therapeutic areas involved.
The optimal organization and high efficiency have been recognized not only from all local health stakeholders, but also from many well-known international companies, which trust their innovative products to us.